0001214659-20-002804.txt : 20200320 0001214659-20-002804.hdr.sgml : 20200320 20200320163716 ACCESSION NUMBER: 0001214659-20-002804 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200318 FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amado Rafael CENTRAL INDEX KEY: 0001662119 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 20732413 MAIL ADDRESS: STREET 1: 5 ASHWOOD LANE CITY: MALVERN STATE: PA ZIP: 19435 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-48393.xml PRIMARY DOCUMENT X0306 4 2020-03-18 0001737287 Allogene Therapeutics, Inc. ALLO 0001662119 Amado Rafael 210 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 false true false false EVP of R&D and CMO Common Stock 2020-03-18 4 A false 30800 0.00 A 135962 D Stock Option (Right to Buy) 18.22 2020-03-18 4 A false 109600 0.00 A 2030-03-17 Common Stock 109600 109600 D 25% of the shares subject to the stock option shall vest on March 13, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter. Veer Bhavnagri as attorney-in-fact for Rafael Amado 2020-03-20